Showing results (331-340 of 590) with videos related to
Sort By:
Pageof 59
Proceedings of the National Academy of Sciences of the United States of America|August 28, 2003
A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastasesJuan Juan Yin, Khalid S Mohammad, Sanna M Käkönen, et al.Annals of Surgical Oncology|March 22, 2008
Timing of surgical intervention for the intact primary in stage IV breast cancer patientsRoshni Rao, Lei Feng, Henry M Kuerer, et al.Journal of Surgical Oncology|October 20, 2015
The long-term risk of upper-extremity lymphedema is two-fold higher in breast cancer patients than in melanoma patientsRachel K Voss, Kate D Cromwell, Yi-Ju Chiang, et al.Annals of Surgical Oncology|October 29, 2014
Phase 2 Study of Intralesional PV-10 in Refractory Metastatic MelanomaJohn F Thompson, Sanjiv S Agarwala, B Mark Smithers, et al.Annals of Surgical Oncology|July 21, 2010
The prognostic significance of nonsentinel lymph node metastasis in melanomaRussell E Brown, Merrick I Ross, Michael J Edwards, et al.Clinical and Experimental Immunology|September 1, 1999
Anti-neutrophil cytoplasmic antibodies (ANCA) against bactericidal/permeability-increasing protein (BPI) and cystic fibrosis lung diseaseR Mahadeva, A C Dunn, R C Westerbeek, et al.Journal of Surgical Oncology|April 3, 2023
Melanoma metastatic to the adrenal gland: An update on the role of adrenalectomy in multidisciplinary managementElliot A Asare, Sarah B Fisher, Yi-Ju Chiang, et al.Annals of Surgical Oncology|January 5, 2002
Utility of breast sentinel lymph node biopsy using day-before-surgery injection of high-dose 99mTc-labeled sulfur colloidC C Solorzano, M I Ross, E Delpassand, et al.Annals of Surgical Oncology|April 13, 2000
Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical TrialC M Balch, S Soong, M I Ross, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 12, 2009
Effect of granulocyte/macrophage colony-stimulating factor on circulating CD8+ and CD4+ T-cell responses to a multipeptide melanoma vaccine: outcome of a multicenter randomized trialCraig L Slingluff, Gina R Petroni, Walter C Olson, et al.Pageof 59